Decreased concentrations of C5a complement receptor antibodies are associated with relapse in eosinophilic granulomatosis with polyangiitis (EGPA)
Saved in:
| Main Authors: | Gabriela Riemekasten, Sebastian Klapa, Antje Müller, Andreas Koch, Harald Heidecke, Peter Lamprecht, Wataru Kaehler, Sabrina Arnold, Anja Staehle, Christian M Karsten |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-03-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/11/1/e005323.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relapse of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Despite Maintenance Treatment With Low‐Dose Mepolizumab
by: Aurelie Vanthuyne, et al.
Published: (2025-05-01) -
Destructive Upper Airway Disease from Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Very First Case
by: Biplab Saha, et al.
Published: (2019-01-01) -
Eosinophilic Granulomatosis Polyangiitis (EGPA) Masquerading as a Mycotic Aneurysm of the Abdominal Aorta: Case Report and Review of Literature
by: Pooja Kumari, et al.
Published: (2021-01-01) -
Case report: novel NFKB2 variant associated with pediatric eosinophilic granulomatosis with polyangiitis (EGPA) in the COVID-19 pandemic
by: Li Lin, et al.
Published: (2025-03-01) -
Nasal Cytology in Eosinophilic Granulomatosis with Polyangiitis
by: David Longhino, et al.
Published: (2024-06-01)